AlphaStocks

CRVL vs MD

As of Sep 20, 2026, Corvel (CRVL) scores 5.9/10 and Pediatrix Medical Group (MD) 6.9/10 on AlphaStocks' five-model composite, so MD scores higher. CRVL trades 58% above its model fair value; MD trades 25% below its model fair value.

CRVL

CORVEL CORP

5.9

Consider Buy

$70.51

MD

Pediatrix Medical Group, Inc.

6.9

Consider Buy

$25.93

CRVL vs MD: Which is the Better Investment?

CORVEL CORP (CRVL) scores 5.9/10 while Pediatrix Medical Group, Inc. (MD) scores 6.9/10 on AlphaStocks' composite model. Pediatrix Medical Group, Inc. has the higher composite rating of Consider Buy. On a P/E basis, Pediatrix Medical Group, Inc. trades at 13.4x, making it the more attractively priced of the two. Pediatrix Medical Group, Inc. trades further below its estimated fair value.

This comparison is algorithmically generated and is not financial advice.

MetricCRVLMD
Scores & Fundamentals
Composite Score5.9/106.9/10
RatingConsider BuyConsider Buy
Price$70.51$25.93
P/E Ratio33.013.4
ROE11.1%18.8%
Market Cap$4B$2B
Fair Value$44.72$34.74
Dividend Yield
Sector Rank#53 of 168#17 of 168
Model Verdicts
PiotroskiAttractiveAttractive
BuffettLimited DataAttractive
GrahamCautionCaution
LynchLimited DataNeutral
GreenblattLimited DataStrong
View full CRVLanalysis →View full MDanalysis →

Related comparisons

Compare any two stocks →

CRVL vs MD: Which Stock Scores Higher?

CORVEL CORP (CRVL) and Pediatrix Medical Group, Inc. (MD) are both in the Health Care sector. MD currently leads with a composite score of 6.9/10 (Consider Buy) compared to CRVL's 5.9/10 (Consider Buy).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer